Emergent BioSolutions (EBS) Divestments (2023)
Emergent BioSolutions (EBS) recorded quarterly Divestments of $74.9 million in Q2 2023.
Emergent BioSolutions (EBS) Divestments (2023) Analysis & Trends
Emergent BioSolutions' Divestments history runs 1 years deep, the most recent figure standing at $74.9 million for Q2 2023.
- In Q2 2023, Divestments changed N/A year-over-year to $74.9 million; the TTM figure through Dec 2024 stood at $74.9 million (changed 0.0% YoY), while the FY2024 annual figure was $110.2 million, down 59.22% from the prior year.
- Divestments was $74.9 million for Q2 2023 at Emergent BioSolutions.
- In the past five years, Divestments ranged from a high of $74.9 million in Q2 2023 to a low of $74.9 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 42.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 63.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 24.21 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 74.90 Mn |